Group sequential designs for cancer immunotherapy trial with delayed treatment effect

References

• Fleming, T. R., and D. P. Harrington. 1991. Counting processes and survival analysis. New York: John Wiley and Sons.
   Google Scholar
• Gandara, D. R., S. M. Paul, M. Kowanetz, E. Schleifman, W. Zou, Y. Li, A. Rittmeyer, L. Fehrenbacher, G. Otto, C. Malboeuf, et al. 2018. Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab. Nature medicine. 24(9):1441–1448. doi:10.1038/s41591-018-0134-3.
   PubMed Web of Science ®Google Scholar
• Hasegawa, T. 2014. Sample size determination for the weighted log-rank test with the Fleming-Harrington class of weights in cancer vaccine studies. Pharmaceutical Statistics 13 (2):128–135. doi:10.1002/pst.1609.
   PubMed Web of Science ®Google Scholar
• Hasegawa, T. 2016. Group sequential monitoring based on the weighted log-rank test statistic with the Fleming–Harrington class of weights in cancer vaccine studies. Pharmaceutical Statistics 15 (5):412–419. doi:10.1002/pst.1760.
   PubMed Web of Science ®Google Scholar
• Jennison, C., and B. W. Turnbull. 2000. Group sequential tests with applications to clinical trials. Boca Raton, FL: Chapman and Hall/CRC.
   Google Scholar
• Korn, E. L., and B. Freidlin. 2018. Interim futility monitoring assessing immune therapies with a potentially delayed treatment effect. Journal Clinical Oncology 36 (23):2444–2449. doi:10.1200/JCO.2018.77.7144.
   PubMed Web of Science ®Google Scholar
• Lan, K. K. G., and D. L. DeMets. 1983. Discrete sequential boundaries for clinical trials. Biometrika 70 (3):659–663. doi:10.2307/2336502.
   Web of Science ®Google Scholar
• Lan, K. K. G., and D. M. Zucker. 1993. Sequential monitoring of clinical trials: The role of information and brownian motion. Statistics in Medicine 12 (8):753–765. doi:10.1002/sim.4780120804.
   PubMed Web of Science ®Google Scholar
• Li, W., Y. P. Chen, and A. Rong. 2019. Estimation of delay time in survival data with delayed treatment effect. Journal of Biopharmaceutical Statistics 29 (2):229–243. doi:10.1080/10543406.2018.1534857.
   PubMed Web of Science ®Google Scholar
• Li, B., L. Su, J. Gao, J. Liyun Jiang, and F. Yan. 2021. A group sequential design and sample size estimation for an immunotherapy trial with a delayed treatment effect. Statistical Methods in Medical Research 30 (3):904–915. doi:10.1177/0962280220980780.
   PubMed Web of Science ®Google Scholar
• Magirr, D., and J. L. Jimenez. 2022. Designing group sequential clinical trials when a delayed effect is anticipated: A practical guidance. Clinical Trial 19 (2):201–210. doi:10.1177/17407745211072848.
   PubMedGoogle Scholar
• Schoenfeld, D. 1981. The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 68 (1):316–319. doi:10.1093/biomet/68.1.316.
   Web of Science ®Google Scholar
• Tsiatis, A. A. 1982. Repeated significance testing for a general class of statistics used in censored survival analysis. Journal of the American Statistical Association 77 (380):855–861. doi:10.1080/01621459.1982.10477898.
   Web of Science ®Google Scholar
• Xiong, X. 1995. A class of sequential conditional probability ratio tests. Journal of American Statistics Association 90 (432):1463–1473. doi:10.1080/01621459.1995.10476653.
   Web of Science ®Google Scholar
• Xiong, X. 2017. A computer program for SCPRT on information time. Version 1 (0).
   Google Scholar
• Xiong, X., M. Tan, and J. Boyett. 2003. Sequential conditional probability ratio tests for normalized test statistic on information time. Biometrics 59 (3):624–631. doi:10.1111/1541-0420.00072.
   PubMed Web of Science ®Google Scholar
• Xiong, X., M. Tan, and M. H. Kutner. 2002. Computational methods for evaluating sequential tests and post-test estimations via sufficiency principle sufficiency. Statistica Sinica 12:1027–1041.
   Web of Science ®Google Scholar
• Xu, Z., B. Zhen, Y. Park, and B. Zhu. 2016. Designing therapeutic cancer vaccine trials with delayed treatment effect. Statistics in Medicine 36 (4):592–605. doi:10.1002/sim.7157.
   PubMed Web of Science ®Google Scholar
• Zhang, J., and E. Pulkstenis. 2016. Sample size and power of survival trials in group sequential design with delayed treatment effect. Statistics in Biopharmaceutical Research 8 (3):268–275. doi:10.1080/19466315.2016.1207560.
   Web of Science ®Google Scholar